Added to chemotherapy, this drug doubles lung cancer survival

Adding immunotherapy to chemotherapy doubled survival in a trial of metastatic nonsquamous non-small cell lung cancer lacking EGFR and ALK mutations.

from Healthmix https://ift.tt/2qI8MXE